Sponsor Pipeline

Feng Liu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07683507 Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma Not Yet Recruiting
Disease Areas
Get alerts when Feng Liu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free